Gastroenterology
Volume 134, Issue 1 , Pages 348-351 , January 2008

HCV, Iron, and Oxidative Stress: The New Choreography of Hepcidin

  • Debbie Trinder

      Affiliations

    • School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, Western Australia
    • ,
  • Oyekoya T. Ayonrinde

      Affiliations

    • Department of Gastroenterology, Fremantle Hospital, Fremantle, Western Australia
    • ,
  • John K. Olynyk

      Affiliations

    • The Western Australian Institute of Medical Research, Perth, Western Australia
    • Corresponding Author InformationAddress requests for reprints to: John K. Olynyk, MD, School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital Campus, Fremantle, Western Australia.

References 

  1. Poynard T, Ratziu V, Charlotte F, et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol. 2001;34:730–739
  2. Olynyk JK, Bacon BR. Hepatitis and iron. In:  Liang TJ,  Hoofnagle J editor. Hepatitis C: Biomedical research reports. San Diego, CA: Academic Press; 2000;p. 415–426
  3. Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the Third National Health and Nutrition Examination Survey. Clin Infect Dis. 2005;40:834–841
  4. Griffiths A, Olynyk JK. Iron and the response to treatment of hepatitis C. Am J Gastroenterol. 2002;97:788–790
  5. Olynyk JK, Reddy KR, Dibisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon-alfa therapy in chronic hepatitis-C. Gastroenterology. 1995;108:1104–1109
  6. Thorburn D, Curry G, Spooner R, et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut. 2002;50:248–252
  7. Fujita N, Sugimoto R, Urawa N, et al. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol. 2007;22:1886–1893
  8. Hofer H, Osterreicher C, Jessner W, et al. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C. J Hepatol. 2004;40:1018–1022
  9. Yano M, Hayashi H, Yoshioka K, et al. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol. 2004;39:570–574
  10. Fontana RJ, Israel J, LeClair P, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial. Hepatology. 2000;31:730–736
  11. Sartori M, Andorno S, Rigamonti C, et al. Chronic hepatitis C is mild in menstruating women. J Gastroenterol Hepatol. 2000;15:1411–1417
  12. Nishina S, Hino K, Korenaga M, et al. Hepatitis C virus–induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology. 2008;134:226–238
  13. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is over expressed during iron overload. J Biol Chem. 2001;276:7811–7819
  14. Harrison-Findik DD, Schafer D, et al. Alcohol metabolism-mediated xidative stress down-regulated hepcidin transcription and leads to increased duodenal iron transporter. J Biol Chem. 2006;281:22974–22982
  15. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299–309
  16. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275:19906–19912
  17. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093
  18. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204–3209
  19. Verga Falzacappa MV, Vujic Spasic M, Kessler R, et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007;109:353–358
  20. Courselaud B, Pigeon C, Inoue Y, et al. C/EBPa regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. J Biol Chem. 2002;277:41163–41170
  21. Bek MF, Bayer M, Muller B, et al. Expression and function of C/EBP homology protein (GADD153) in podocytes. Am J Pathol. 2006;168:20–32
  22. Fujita N, Sugimoto R, Takeo M, et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med. 2007;13:97–104
  23. Aoki CA, Rossaro L, Ramsamooi R, et al. Liver hepcidin mRNA correlates with iron stores but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol. 2005;39:71–74
  24. Nagashima M, Kudo M, Chung H, et al. Regulatory failure of seum prohepcidin levels in patients with hepatitis C. Hepatol Res. 2006;6;:288–293
  25. Fujita N, Horike S, Sugimoto R, et al. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. Free Rad Biol. 2007;42:353–362
  26. Saito H, Fujimoto Y, Ohtake T, et al. Up-regulation of transferrin receptor 1 in chronic hepatitis C: Implication in excess hepatic iron accumulation. Hepatol Res. 2005;31:203–210
  27. Takeo M, Kobayashi Y, Fujita N, et al. Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. J Gastroenterol Hepatol. 2005;20:562–569
  28. Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood. 2004;104:4287–4293
  29. Graham RM, Chua AC, Herbison CE, et al. Liver iron transport. World J Gastroenterol. 2007;13:4725–4736
  30. Bridle K, Cheung T-K, Murphy TL, et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin and Exp Res. 2006;30:106–112
  31. Ohtake T, Saito H, Hosoki Y, et al. Hepcidin is down-regulated in alcohol loading. Alcohol Clin and Exp Res. 2007;31:2S–8S
  32. Harrison-Findik DD. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology. 2007;Aug 30; [Epub ahead of print]
  33. Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA. 1998;95:2492–2497
  34. Brunt EM, Olynyk JK, Britton RS, et al. Histological evaluation of iron in liver biopsies: Relationship to HFE mutations. Am J Gastroenterol. 2000;95:1788–1793
  35. Ayonrinde OT, Olynyk JK. Clinical expression of hemochromatosis gene (HFE) variants. Hepatology. 2007;46:960–962
  36. Nahon P, Sutton A, Rufat P, et al. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis. Gastroenterology. 2008;134:102–110

PII: S0016-5085(07)02125-7

doi: 10.1053/j.gastro.2007.11.048

Gastroenterology
Volume 134, Issue 1 , Pages 348-351 , January 2008

Article Tools

* Image Usage & Resolution